Maxcyte (MXCT) Other Non Operating Income (2020 - 2026)

Maxcyte (MXCT) has 7 years of Other Non Operating Income data on file, last reported at $1.4 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 29.45% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $644000.0, a 300.0% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 216.28% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $1.4 million, up from -$4.4 million in the prior quarter.
• Over the last five years, Other Non Operating Income for MXCT reached as high as $2.8 million in Q4 2023 and fell as low as -$7.4 million in Q4 2024.
• Historically, Other Non Operating Income has averaged $1.0 million across 5 years, with a median of $1.9 million in 2022.
• Across the five-year window, Other Non Operating Income jumped 10506.52% in 2022 and slumped 364.19% in 2024, its largest moves.
• Year by year, Other Non Operating Income stood at $1.9 million in 2022, then surged by 45.18% to $2.8 million in 2023, then slumped by 364.19% to -$7.4 million in 2024, then soared by 40.98% to -$4.4 million in 2025, then jumped by 132.66% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $1.4 million in Q1 2026, -$4.4 million in Q4 2025, and $1.7 million in Q3 2025.